J3403 Revakinagene, per implant
J-Codes
Also known as: revakinagene autotemcel, TIL therapy, tumor-infiltrating lymphocyte therapy
Revakinagene autotemcel per implant injection is autologous T cell immunotherapy for melanoma treatment.
Clinical Context
Autologous tumor-infiltrating lymphocytes isolated from resected melanoma, expanded, and reinfused. Intravenous administration to treat metastatic melanoma. Enhances anti-tumor immune response.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.